Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Important TIPS for KOL Mapping
Summary
In this episode, Keely Dahl shares her expertise on KOL mapping, offering valuable insights into identifying and ranking key opinion leaders. She outlines the importance of cross-functional coordination in engaging with KOLs and provides strategies for acquiring meetings and optimizing contact lists. Keely discusses effective outreach methods, including email and phone communication, and emphasizes the significance of networking at conferences. The episode concludes with best practices for email communication and essential advice for MSLs aiming to enhance their KOL mapping skills.
Keely Dahl, Sr Medical Science Liaison at Aurinia Pharmaceuticals shares important tips for KOL mapping based on her real life experience
Keely shares…
👉 What is KOL Mapping and how to build your list
👉 Best ways to coordinate with cross functional partners
👉 Unique ways to engage with KOLs and gain better access
👉 How to maintain and prioritize your list
👉 Advice for closing out the year on a strong note
KOL mapping, key opinion leaders, cross-functional coordination, outreach methods, Medical Science Liaison
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO